AzTrials
AzTrials

Night Shift WorkSHAPENCT07631767

Shift Workers' Health Behavior Action Program Across Europe

A study testing Combined Lifestyle Intervention in people with Night Shift Work and Obesity & Overweight, run by Wageningen University at 5 sites in 3 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study evaluates the effects of a Combined Lifestyle Intervention Program (CLIP) on sleep, lifestyle behaviors, obesity risk and health in night-shift workers. The primary objective is to assess the effect of the CLIP on objectively measured sleep duration. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
What is being tested?
Combined Lifestyle Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
5 sitesin 3 countries
Study dates
15 May 2026to 1 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age ≥ 21 years
  • Work ≥ 24 hours per week
  • Shift work duration > 3 years and currently doing night shifts
  • Expected to continue night shiftwork for at least 1 year after inclusion
  • On average working ≥ 4 night shifts per month
  • Working generally ≥ 2 consecutive night shifts
  • In possession of a smartphone and willing to download the study application

Who cannot join

  • Body Mass Index (BMI) < 18.5 or > 40 kg/m2
  • Pregnant or lactating
  • Chronic diseases with ongoing therapy (e.g. renal failure, active hepatitis, cirrhosis, myocardial infarction, chronic obstructive pulmonary disease and cancer)
  • Current or recent use of medications interfering with sleep, including: Central nervous system stimulants (e.g., Ritalin, Adderall, Modafinil or similar); Chronic use of sleep agents (e.g., benzodiazepine, non-hypnotic benzodiaze-pine, first-generation antihistamine, melatonin receptors agonists or similar); Other medications or combinations significantly affecting sleeping patterns
  • Recent or ongoing psychotherapy for sleep disorders
  • Current or recent use of medications affecting appetite or weight regulation, including: Appetite-enhancing/weight-gain medications (e.g., atypical antipsychotics, cor-ticosteroids such as prednisone, mirtazapine or similar); Appetite-suppressing/weight-loss medications (e.g., CNS stimulants such as Ritalin, Adderall, GLP-1 receptors agonists or similar); Other medications or combinations significantly influencing appetite or body weight
Show all 9Show fewer
  • Participation in another human trial, lifestyle program or weight loss intervention within the past 3 months
  • Planned surgical procedure during the study period
  • History of or planned bariatric surgery/treatment

Trial locations and contacts

5 sites in 3 countries. Contact the study team or a site near you to ask about taking part.

5 sites in 3 countries

Germany2 sites, 2 recruiting
  • Uni Bremen

    Bremen

    U. Klink, 0049 421 218 68980

    Recruiting
  • TTZ

    Bremerhaven

    Not yet recruiting

Other trials in Germany

Netherlands2 sites, 2 recruiting
  • Erasmus Medical Centre

    Rotterdam

    H. Lammers-van der Holst, 0031 10 704 0704

    Recruiting
  • Wageningen University & Research

    Wageningen

    M. Mensink, 0031 (0)317 480 100

    Recruiting

Other trials in Netherlands

Poland1 site, 1 recruiting
  • Lodz

    Lodz

    M. Wrzesińska, 0048 42 272 58 13, prorektor.int@umed.lodz.pl

    Not yet recruiting

Other trials in Poland

About this study

This study evaluates the effects of a Combined Lifestyle Intervention Program (CLIP) on sleep, lifestyle behaviors, obesity risk and health in night-shift workers. The primary objective is to assess the effect of the CLIP on objectively measured sleep duration. Secondary objectives include behavioral outcomes related to sleep, diet, physical activity, and stress, as well as body weight and metabolic outcomes, . It is hypothesized that CLIP participants will show a greater increase in sleep duration than controls, alongside favorable changes in lifestyle and health outcomes.

Being tested
Combined Lifestyle Intervention
Keywords
Lifestyle, Stress, Sleep, Diet, Physical Activity
Medical subject headings
Obesity, Overweight, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined Lifestyle InterventionBehavioural

    The 24-week lifestyle intervention is structured in four 6-week blocks focusing on sleep and stress management or diet and physical activity. Lifestyle advice and behavior change techniques are delivered via a mobile application, complemented by workshops.

Study groups in NCT07631767
Study groupRoleWhat they receive
InterventionExperimentalIntervention group receives access to the 24-week combined lifestyle intrevention, which includes the mobile intervention app and four interactive workshops.
Receives: Behavioral: Combined Lifestyle Intervention
ControlNo interventionThe control group receives informational brochures with general advice on the four life-style domains, without active behavioral support. The control group receives access to the combined lifestyle intrevention after the intervention period has ended.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sleep duration

    Total sleep time (min/24h)

    Measured: From enrollment to the end of intervention (24 weeks)

Secondary outcomes (13)
  1. Body weight

    (kg)

    Measured: From enrollment to end of intervention (24 weeks)

  2. BMI

    (kg/m2)

    Measured: From enrollment to end of intervention (24 weeks)

  3. Objective sleep quality

    Wake after sleep onset (min spent awake/main sleep episode), derived from actigraphy data

    Measured: From enrollment to end of intervention (24 weeks)

  4. Overall diet quality

    Diet quality score: Eetscore™, a 55-item FFQ which is scored with the Dutch Healthy Diet 2015-index to evaluate adherence to the Dutch food-based dietary guideline; resulting in a total score between zero (no adherence) and 100 (complete adherence).

    Measured: From enrollment to end of intervention (24 weeks)

  5. Physical activity level

    Light, moderate, vigorous activity (min), Sedentary time (min) as measured with an actigraphy (Motionwatch)

    Measured: From enrollment to end of intervention (24 weeks)

  6. Perceived stress

    Perceived stress score (PSS-10), a 10-item validated questionnaire assessing the extent to which individuals perceive their lives as unpredictable, uncontrollable, and overloaded. Items are rated on a 5-point Likert scale referring to experiences over the past month; higher score mean more stress.

    Measured: From enrollment to end of intervention (24 weeks)

  7. Subjective sleep quality (Insomina)

    Insomnia severity (0-28): a 7-item self-administered questionnaire validated in shift workers as a proxy for sleep quality. Items assess the severity of insomnia symptoms, including difficulties with sleep onset, maintenance, and early awakening. Each item is scored 0-4, with total scores ranging from 0 to 28; higher scores indicate more severe insomnia

    Measured: From enrollment to end of intervention (24 weeks)

  8. Subjective leep quality (pattern)

    Shift Work Disorder Questionnaire (SWDQ): a 4-item questionnaire assessing sleep patterns, excessive sleepiness, and functional impairment related to shift work (53). Each item is scored 1-4, yielding a total score of 4-16, with higher scores reflecting greater symptom severit

    Measured: [Time Frame: From enrollment to end of intervention (24 weeks)]

  9. Chrono-nutrition patterns

    Meal timing, frequency, regularity; using the Chrono nutrition Questionnaire for Shift Workers (CNQ-Shift). The questionnaire contains 20-23 questions, five questions each for morning, afternoon, and night shifts, three split shifts questions (if applicable), and two questions for work-free days.

    Measured: From enrollment to end of intervention (24 weeks)

  10. Food preferences

    FFPQ (liking/wanting scores): Participants rate "how pleasant it would be to try a bite of this food," using a 100-point visual analogue scale (explicit liking). A forced choice procedure is then carried used to assess which food participants would "most like to eat now" (implicit wanting).

    Measured: From enrollment to end of intervention (24 weeks)

  11. Occupational physical activity

    OSPAQ (min)

    Measured: From enrollment to end of intervention (24 weeks)

  12. Work-related sense of coherence

    Work-related sense of coherence Work-Soc (5-point Likert scale), a 9-scale assessing individuals' perceived comprehensibility, manageability, and meaningfulness at work.

    Measured: From enrollment to end of intervention (24 weeks)

  13. Satisfaction With Life

    Satisfaction With Life Scale (SWLS): a 5-item questionnaire evaluating global life satisfaction (66). Items are rated on a 7-point scale

    Measured: [Time Frame: From enrollment to end of intervention (24 weeks)]

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2026
  2. Study start15 May 2026
  3. Primary completion1 Jul 2027 (estimated)
  4. Study completion1 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07631767
Sponsor's protocol ID
NL-010791
Acronym
SHAPE
Status last verified
May 2026
First submitted
1 May 2026
Last updated
20 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Combined Lifestyle Intervention in people with Night Shift Work and Obesity & Overweight, run by Wageningen University at 5 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Germany, Netherlands, Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sleep duration (time frame: From enrollment to the end of intervention (24 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in